C

Crown Bioscience Tech Stack

Contract research organization for oncology drug development and PDX modeling

Biotechnology Research San Diego, California 1,001–5,000 employees Public Company

Crown Bioscience is a mid-to-large CRO focused on oncology and immuno-oncology research, operating 11 facilities across North America, Europe, and APAC. The hiring mix skews heavily toward research roles with a secondary focus on business development and quality operations—a profile aligned with their active push into China, portfolio expansion, and internal quality-compliance tightening. Pain points center on workflow optimization, protocol improvement, and equipment reliability, suggesting operational scaling challenges as they pursue new pharma partnerships.

Tech Stack 10 technologies

Core StackMicrosoft Office Excel GraphPad Prism LC-MS/MS UHPLC HPLC Phoenix WinNonlin LC-MS PowerPoint Word

What Crown Bioscience Is Building

◆Challenges

Improving site quality compliance
Optimizing program workflows
Improving study protocols
Market competitive gaps
Portfolio growth challenges
Reducing equipment downtime
Improving site quality and efficiency
Compliance with regulations
Risk mitigation of quality breaks
Meeting strict timelines

▲Active Projects

New business development in china
Client audit and supplier qualification program
Capa plan development
Site internal audit program
Strategic sales plans for top 25 global pharma accounts
New product introduction
Candidate molecule identification and characterization
Pk/pd and tox study design
Capa system implementation
Eu/global qms improvements

Hiring Activity

Steady30 roles · 10 in 30d

Department

Research

20

Sales

4

Ops

2

Product

2

Quality

1

Seniority

Mid

9

Director

8

Senior

6

Junior

5

Manager

1

Notable leadership hires: Business Development Director, Study Director, Director

Company intelligence

Find more companies like Crown Bioscience by tech stack, pain points and active projects

Get started free

About Crown Bioscience

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization specializing in preclinical, translational, and clinical support for oncology and immuno-oncology drug programs. The firm operates one of the world's largest commercially available patient-derived xenograft (PDX) collections and approximately 1,000 tumor organoid models, covering 35 cancer indications. Their service portfolio spans in vivo, in vitro, ex vivo, and in silico research methods, biomarker discovery, and biospecimen banking with clinical histories. Facilities across the US, Europe, and APAC hold CAP and ISO accreditation. Client base comprises biotech and pharmaceutical companies ranging from mid-market to top-tier global accounts.

HeadquartersSan Diego, California

Company Size1,001–5,000 employees

Hiring MarketsUnited States, China, Australia, United Kingdom

Frequently Asked Questions

What is Crown Bioscience's PDX collection size?

Crown Bioscience operates the world's largest commercially available patient-derived xenograft collection, complemented by approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, spanning 35 cancer indications.

Where does Crown Bioscience have facilities?

Crown Bioscience operates 11 state-of-the-art facilities across the United States, Europe, and APAC, all meeting CAP and ISO accreditation standards.

Is Crown Bioscience hiring in China?

Yes. Crown Bioscience has active hiring in the United States, China, Australia, and the United Kingdom, with new business development in China listed as a current strategic project.